How Cochrane's partners recognise and define our success

Oufemi Oladapo, Medical Officer, Department of Reproductive Health and Research, World Health Organization: "I think without the Cochrane Pregnancy and Childbirth Group, my team - that's the team of maternal and perinatal health - wouldn't have been able to issue as many recommendations as we have since the establishment of the WHO Guideline Review Committee. We have over 200 recommendations, clinical recommendations, based on close to 250 systematic reviews, and the majority of those are Cochrane reviews."

Dr Marie Paule Kieny, Assistant Director-General, Health Systems and Innovation, World Health Organization: "The collaboration with Cochrane is very important for WHO, and this is why we value this partnership. Cochrane is one of the major institutions, at the global level in particular, to synthesise, to analyse and to disseminate evidence, so that this evidence can be used by WHO in the guideline process."

Gabriel Rada, Co-Founder and President, Epistemonikos Foundation: "Being a partner with Cochrane is something that is very important for us, and we think helps us achieve the mission of Epistemonikos Foundation. The branding and the reliability that Cochrane has built for years in the world is something that takes a lot of effort."

James Heilman, Emergency Physician and Wikipedian: "Since 2012 we have seen a substantial increase in the number of times Cochrane reviews are referenced on Wikipedia. Cochrane is producing excellent evidence; Wikipedia has this incredible audience - you join the evidence with the audience and, you know, you end up with a magical partnership."

Richard Rosenfeld, MD, Chairperson of the Guideline Development Task Force, American Academy of Otolaryngology: "Cochrane is to reviews what guideline network is to guidelines. There's aspects of methodology, there's aspects of networking, there's best practices, and there's engagement. And the two worlds have to speak."

Bryan Rumble, Guideline Specialist, American Society of Clinical Oncology: "You're making something that is desperately needed, it's the evidentiary base. The Cochrane Group, in my experience, is the go-to for systematic reviews.

Karel GM Moons, Professor of Epidemiology, Julius Center for Health Sciences and Primary Care, UMC Utrecht: "I think there is no such well organised medical community as Cochrane. Almost every university in this world that matters is linked somehow, either through a clinician or a methodologist or a librarian or a technician - linked to Cochrane."

Richard Rosenfeld, MD, Chairperson of the Guideline Development Task Force, American Academy of Otolaryngology: "The one thing that Cochrane could do to really make the greatest difference in informing current and future guidelines is to be relevant to what the guideline developers need..."

Belinda Ireland, MD, Clinical Epidemiologist and Guideline Consultant: "...so that systematic reviews do focus on topics that are important to physicians and their patients."

Oufemi Oladapo, Medical Officer, Department of Reproductive Health and Research, World Health Organization: "What will determine the success of the relationship is when all priority questions that WHO comes up with, can be answered by existing Cochrane reviews - that will be a perfect match."